The potential for stem cells derived from menstrual blood to benefit stroke sufferers will be jointly investigated by researchers at the University of South Florida, Cryo-Cell International, Inc. a global stem cell company based in Oldsmar, FL, and Saneron CCEL Therapeutics, Inc., a Tampa-based biotechnology company.
The research team is supported by a $100,000 grant from the Florida-based Technology Transfer/ Commercialization Partnership Grant through the James and Esther King Biomedical Research Program, and a Florida Hi-Tech Corridor Industry Seed Matching Grant from USF Connect for another $52,000.
“Recent laboratory studies using animal models have shown transplanted menstrual blood-derived stem cells produced therapeutic effects following stroke,” said Dr. Cesar Borlongan, co-principal investigator and a USF neuroscientist. “We will be testing the possibility that these cells promote the growth of blood vessels and neurons that can aid in brain repair following stroke.”
1 Trackback or Pingback
[...] USF study to investigate menstrual blood-derived stem cells as potential stroke therapy « Flor… [...]